HCW Biologics Inc. Receives Nasdaq Listing Compliance Notice

What Happened
HCW Biologics Inc. announced on June 29, 2026 that the Nasdaq Listing Qualifications Staff notified the company the Nasdaq Hearings Panel found HCWB regained compliance with Listing Rule 5550(a)(2) (the “Bid Price Rule”) per the Panel’s May 29, 2026 decision (as amended). The Panel’s decision conditions require the company to satisfy remaining terms through September 22, 2026. If those conditions are met, the Panel intends to impose a Discretionary Panel Monitor for one year beginning then, and in any event the company will be subject to a Mandatory Panel Monitor until June 17, 2027.

Key Details

• Nasdaq notified HCW Biologics on June 29, 2026 that the Panel found the company regained compliance with the Bid Price Rule (Listing Rule 5550(a)(2)).
• If the company meets remaining Panel conditions through Sept 22, 2026, a one‑year Discretionary Panel Monitor will be imposed per Listing Rule 5815(d)(4)(A).
• Under Listing Rule 5815(d)(4)(B) the company will be under a Mandatory Panel Monitor until June 17, 2027.
• If Staff finds the company out of compliance with the Bid Price Rule during the one‑year monitoring period, Nasdaq will issue a Delist Determination Letter and the company will not be allowed an additional cure period under Rule 5810(c); the company may request a hearing before a Hearings Panel.

Why It Matters
This filing informs investors that HCW Biologics has regained compliance with Nasdaq’s minimum bid-price requirement but will be monitored closely for up to a year (and mandatorily until June 17, 2027). The monitoring increases regulatory oversight and shortens the typical opportunities to cure any future bid-price deficiency: if the company slips back out of compliance during the monitored period, Nasdaq can move quickly toward delisting. Investors should watch the company’s share price relative to Nasdaq’s bid‑price standard and any further Nasdaq communications or company updates through the September 22, 2026 and June 17, 2027 milestones.